HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ameliorative effects of SkQ1 eye drops on cataractogenesis in senescence-accelerated OXYS rats.

AbstractBACKGROUND:
Antioxidant supplements have been suggested as a strategy to decrease the risk of age-related cataract, but there is no evidence that antioxidants can reduce the signs of the disease. Recently, we showed that the mitochondrial antioxidant SkQ1 can partially reverse cataract signs in senescence-accelerated OXYS rats. The aim of the present study was the histomorphological examination of the influence of SkQ1 eye drops on the cataract development in OXYS rats.
METHODS:
OXYS rats received SkQ1 eye drops (250 nM) from 9 to 12 months of age. Ophthalmoscopic examination was carried out before and after treatment. Light and electron microscopy were used for histomorphological examination. Expression of the Cryaa and Cryab genes was determined using real-time PCR. αB-crystallin expression was detected using Western blotting.
RESULTS:
SkQ1 completely prevented the cataract development in OXYS rats, and in some of the animals diminished the signs of the disease. Light and electron microscopy showed that SkQ1 attenuated the (typical for cataract) alterations in the lens capsule and epithelial cells, ameliorated disturbances of the hexagonal packing geometry of lens fibers, and improved ultrastructure of the epithelial cells. The levels of mRNA of α-crystallins genes which encode small heat shock proteins αA- and αB-crystallin that play a central role in maintaining lens transparency were significantly lower in the OXYS rats' lenses than in Wistar rats (control). SkQ1 normalized the level of mRNA of Cryaa, and significantly increased the level of Cryab mRNA as well as αB-crystallin protein in the lens of OXYS rats to the level of the control Wistar rats.
CONCLUSION:
SkQ1 eye drops hold promise as a treatment of cataract.
AuthorsYuliya V Rumyantseva, Elena I Ryabchikova, Anjela Z Fursova, Nataliya G Kolosova
JournalGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (Graefes Arch Clin Exp Ophthalmol) Vol. 253 Issue 2 Pg. 237-48 (Feb 2015) ISSN: 1435-702X [Electronic] Germany
PMID25267419 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 10-(6'-plastoquinonyl)decyltriphenylphosphonium
  • Antioxidants
  • Crystallins
  • Free Radical Scavengers
  • Microtubule-Associated Proteins
  • Ophthalmic Solutions
  • RNA, Messenger
  • alpha-Crystallin A Chain
  • alpha-Crystallin B Chain
  • cryaB protein, rat
  • Plastoquinone
Topics
  • Aging
  • Animals
  • Antioxidants (administration & dosage)
  • Blotting, Western
  • Cataract (genetics, prevention & control)
  • Crystallins
  • Disease Models, Animal
  • Free Radical Scavengers
  • Gene Expression
  • Male
  • Microtubule-Associated Proteins
  • Ophthalmic Solutions
  • Plastoquinone (administration & dosage, analogs & derivatives)
  • RNA, Messenger (genetics)
  • Rats
  • Rats, Wistar
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcription
  • alpha-Crystallin A Chain (genetics)
  • alpha-Crystallin B Chain (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: